Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.

Pages